title: Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.
authors.affiliation: Institute for Clinical Evaluative Sciences, Toronto Ont. alaupacis@ices.on.ca
authors.forename: Andreas
authors.initials: A
authors.lastname: Laupacis
authors.forename: J Michael
authors.initials: JM
authors.lastname: Paterson
authors.forename: Muhammad
authors.initials: M
authors.lastname: Mamdani
authors.forename: Alaa
authors.initials: A
authors.lastname: Rostom
authors.forename: Geoffrey M
authors.initials: GM
authors.lastname: Anderson
mesh_terms: D002170:Canada; D004341:Drug Evaluation / Q000592:standards / Q000639:trends*; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D019370:Observation / Q000379:methods; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D016032:Randomized Controlled Trials as Topic